Researchers find marker for urothelial cancer:
This article was originally published in Clinica
Measuring the level of a protein called angiogenin in tumour tissue and serum of patients with urothelial carcinoma could help doctors determine their prognosis. The mean level of angiogenin expression was four times higher in invasive urothelial carcinomas than in superficial carcinomas and five times higher than in normal tissue, a Canadian and Japanese research team revealed in the July issue of Cancer.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.